2014 About Push Health Push Health was founded in 2014 as a telehealth marketplace that connects patients directly with licensed healthcare providers for prescription services
Now, a US-wide trial will test whether tirzepatide, the active ingredient in Zepbound, may be an effective treatment for people with long Covid
Starting in 2026, Eli Lilly (Lilly) and Novo Nordisk will lower prices on some GLP-1 drugs for Medicare and Medicaid beneficiaries, and those who pay out of pocket
In the future, the global Semaglutide API market will be steady with incremental growth
Factors Contributing to GLP-1 Availability Challenges and Solutions Multiple systemic factors influenced GLP-1 supply dynamics: unprecedented demand surge from diabetes and weight-loss indications, specialized manufacturing requirements for injectable formulations, regulatory approval delays for new production facilities, and competing global demand
Most cases relate to the medication's impact on blood glucose levels, blood pressure, hydration status, or gastrointestinal function